Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-6512
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies ; volume:11 ; number:1 ; day:16 ; month:6 ; year:2020 ; pages:1-14 ; date:12.2020
Stem cell research & therapy ; 11, Heft 1 (16.6.2020), 1-14, 12.2020
- Urheber
-
Shankar, Keerthana
Capitini, Christian M.
Saha, Krishanu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13287-020-01741-4
- URN
-
urn:nbn:de:101:1-2020081321254565874989
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shankar, Keerthana
- Capitini, Christian M.
- Saha, Krishanu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pluripotent- and multipotent-stem cell derived hematopoietic cells and their use for regenerative therapies
Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
Islet-like clusters derived from pluripotent stem cells (SC-islets) as mini organs for diabetes cell therapies
Human pluripotent stem cell differentiation to functional pancreatic cells for diabetes therapies: Innovations, challenges and future directions
Perspectives on the cost of goods for hPSC banks for manufacture of cell therapies
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
Moving Towards Induced Pluripotent Stem Cell-based Therapies with Artificial Intelligence and Machine Learning
Microencapsulation-based cell therapies
Retrotransposons in pluripotent stem cells
Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells
Cell therapies for pancreatic beta-cell replenishment
Cell-Based Therapies with T Regulatory Cells
Pluripotent- and multipotent-stem cell derived hematopoietic cells and their use for regenerative therapies
Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
Islet-like clusters derived from pluripotent stem cells (SC-islets) as mini organs for diabetes cell therapies
Human pluripotent stem cell differentiation to functional pancreatic cells for diabetes therapies: Innovations, challenges and future directions
Perspectives on the cost of goods for hPSC banks for manufacture of cell therapies
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
Moving Towards Induced Pluripotent Stem Cell-based Therapies with Artificial Intelligence and Machine Learning
Microencapsulation-based cell therapies
Retrotransposons in pluripotent stem cells
Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells
Cell therapies for pancreatic beta-cell replenishment
Cell-Based Therapies with T Regulatory Cells
Pluripotent- and multipotent-stem cell derived hematopoietic cells and their use for regenerative therapies
Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
Islet-like clusters derived from pluripotent stem cells (SC-islets) as mini organs for diabetes cell therapies
Human pluripotent stem cell differentiation to functional pancreatic cells for diabetes therapies: Innovations, challenges and future directions
Perspectives on the cost of goods for hPSC banks for manufacture of cell therapies
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
Moving Towards Induced Pluripotent Stem Cell-based Therapies with Artificial Intelligence and Machine Learning
Microencapsulation-based cell therapies
Retrotransposons in pluripotent stem cells
Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells
Cell therapies for pancreatic beta-cell replenishment